Cargando…
Myeloid Neoplasias: What Molecular Analyses Are Telling Us
In the last decades, cytogenetic and molecular characterizations of hematological disorders at diagnosis and followup have been most valuable for guiding therapeutic decisions and prognosis. Genetic and epigenetic alterations detected by different procedures have been associated to different cancer...
Autores principales: | Gutiyama, Luciana M., Coutinho, Diego F., Lipkin, Marina V., Zalcberg, Ilana R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465937/ https://www.ncbi.nlm.nih.gov/pubmed/23056961 http://dx.doi.org/10.5402/2012/321246 |
Ejemplares similares
-
Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition
por: Baptista, Renata Lyrio Rafael, et al.
Publicado: (2017) -
Biomolecular Condensates in Myeloid Leukemia: What Do They Tell Us?
por: Jevtic, Zivojin, et al.
Publicado: (2023) -
Acute Myeloid Leukemia Expresses a Specific Group of Olfactory Receptors
por: Guardia, Gabriela D. A., et al.
Publicado: (2023) -
Myeloid malignancies‐related somatic mutations in aging individuals
por: Coutinho, Diego F., et al.
Publicado: (2019) -
What is AMS telling us?
Publicado: (2016)